The current state of financial environment and the ever-changing conditions within the pharmaceutical and biotechnology industries has placed tremendous pressures on executives to reduce operating expenses, timelines, and overall efficiencies. While certainly this is a top priority within all divisions of these organizations, it is even more critical across the supply chain. A pharmaceutical supply chain is truly unlike any other supply chain for any other type of product, in complexity, cost, and regulation. No other product has such a high risk associated with potential contamination or instability of ingredient, sterilization and stability of packaging, as well as overall transport from factory to consumer, which needs to be strictly monitored and maintained. For that reason, it is critical for executives from the pharmaceutical and biotech industries to gather to discuss and challenge each other with the problems and hurdles that they face in continuing to produce the most from their supply chains.
This extensive two day conference program is focused on bringing key industry leaders and executives together to network, knowledge share and openly discuss the challenges and hurdles that they face on a day-to-day basis within supply chain operations. The ability to learn from each other and share new ideas makes this a must attend for all pharmaceutical and biotech supply chain executives.